Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LabCorp
CRO
Fortrea CEO Thomas Pike steps down amid stock free fall
Fortrea’s stock price has been in free fall over the past year—from around $37 per share in May 2024 to around $5 as of 3 p.m. ET Monday.
Darren Incorvaia
May 12, 2025 5:00pm
Labcorp launches bird flu test amid first severe case in the US
Dec 18, 2024 3:00pm
Labcorp, Quest Diagnostics back PreciseDx's $20.7M series B
Aug 21, 2024 11:00am
Labcorp launches software suite for investigator sites
Jun 18, 2024 12:16pm
Labcorp unveils first-trimester blood test for preeclampsia risk
May 21, 2024 2:30pm
Labcorp nets companion Dx OK for Pfizer hemophilia gene therapy
Apr 29, 2024 1:56pm
